ListedPVA QPPV.com application

Product reference directory

Find a medicinal product.
Follow the reference.

Search brands, INNs, development names and recorded aliases. ListedPV will connect each product to transparent, source-linked reference-label assessments.

100 initial product records

Initial product records

100 products

This discovery directory is not a sales ranking and does not itself represent label-reviewed safety evidence.

Oncology

Keytruda

pembrolizumab

Also: pembro, MK-3475

Immunology

Dupixent

dupilumab

Metabolic

Ozempic

semaglutide

Metabolic

Mounjaro

tirzepatide

Cardiovascular

Eliquis

apixaban

Infectious disease

Biktarvy

bictegravir / emtricitabine / tenofovir alafenamide

Also: BIC/FTC/TAF

Immunology

Stelara

ustekinumab

Immunology

Skyrizi

risankizumab

Immunology

Humira

adalimumab

Immunology

Cosentyx

secukinumab

Immunology

Enbrel

etanercept

Respiratory

Xolair

omalizumab

Oncology

Opdivo

nivolumab

Oncology

Darzalex

daratumumab

Neurology

Ocrevus

ocrelizumab

Ophthalmology

Eylea

aflibercept

Immunology

Rinvoq

upadacitinib

Oncology

Jakafi

ruxolitinib

Oncology

Ibrance

palbociclib

Oncology

Verzenio

abemaciclib

Oncology

Kisqali

ribociclib

Oncology

Tagrisso

osimertinib

Oncology

Imbruvica

ibrutinib

Oncology

Calquence

acalabrutinib

Oncology

Brukinsa

zanubrutinib

Oncology

Revlimid

lenalidomide

Oncology

Pomalyst

pomalidomide

Oncology

Xtandi

enzalutamide

Oncology

Zytiga

abiraterone acetate

Oncology

Lynparza

olaparib

Oncology

Enhertu

trastuzumab deruxtecan

Oncology

Kadcyla

ado-trastuzumab emtansine

Also: trastuzumab emtansine

Oncology

Herceptin

trastuzumab

Oncology

Perjeta

pertuzumab

Oncology

Avastin

bevacizumab

Oncology

Tecentriq

atezolizumab

Oncology

Yervoy

ipilimumab

Oncology

Tecvayli

teclistamab

Oncology

Blincyto

blinatumomab

Oncology

Kymriah

tisagenlecleucel

Cardiovascular

Entresto

sacubitril / valsartan

Cardiovascular

Jardiance

empagliflozin

Cardiovascular

Farxiga

dapagliflozin

Cardiovascular

Xarelto

rivaroxaban

Cardiovascular

Brilinta

ticagrelor

Cardiovascular

Repatha

evolocumab

Cardiovascular

Praluent

alirocumab

Cardiovascular

Leqvio

inclisiran

Urology

Myrbetriq

mirabegron

Metabolic

Lantus

insulin glargine

Metabolic

Toujeo

insulin glargine

Metabolic

Tresiba

insulin degludec

Metabolic

Trulicity

dulaglutide

Metabolic

Januvia

sitagliptin

Cardiovascular

Nexletol

bempedoic acid

Cardiovascular

Vyndaqel

tafamidis meglumine

Cardiovascular

Vyndamax

tafamidis

Neurology

Zeposia

ozanimod

Neurology

Tysabri

natalizumab

Neurology

Kesimpta

ofatumumab

Neurology

Mayzent

siponimod

Neurology

Spinraza

nusinersen

Neurology

Evrysdi

risdiplam

Neurology

Zolgensma

onasemnogene abeparvovec

Haematology

Soliris

eculizumab

Haematology

Ultomiris

ravulizumab

Haematology

Cablivi

caplacizumab

Immunology

Saphnelo

anifrolumab

Immunology

Benlysta

belimumab

Respiratory

Nucala

mepolizumab

Respiratory

Fasenra

benralizumab

Respiratory

Tezspire

tezepelumab

Respiratory

Breo Ellipta

fluticasone furoate / vilanterol

Respiratory

Trelegy Ellipta

fluticasone furoate / umeclidinium / vilanterol

Respiratory

Symbicort

budesonide / formoterol

Respiratory

Spiriva

tiotropium

Infectious disease

Veklury

remdesivir

Infectious disease

Paxlovid

nirmatrelvir / ritonavir

Vaccines

Comirnaty

COVID-19 mRNA vaccine

Also: tozinameran

Vaccines

Shingrix

recombinant zoster vaccine

Vaccines

Gardasil 9

human papillomavirus 9-valent vaccine

Also: HPV vaccine

Vaccines

Prevnar 20

pneumococcal 20-valent conjugate vaccine

Also: PCV20

Vaccines

Arexvy

respiratory syncytial virus vaccine

Also: RSV vaccine

Vaccines

Abrysvo

respiratory syncytial virus vaccine

Also: RSV vaccine

Bone health

Prolia

denosumab

Oncology

Xgeva

denosumab

Bone health

Evenity

romosozumab

Haematology

Nplate

romiplostim

Haematology

Doptelet

avatrombopag

Haematology

Tavalisse

fostamatinib

Oncology

Venclexta

venetoclax

Oncology

Krazati

adagrasib

Oncology

Lumakras

sotorasib

Oncology

Padcev

enfortumab vedotin

Oncology

Trodelvy

sacituzumab govitecan

Oncology

Elrexfio

elranatamab

Oncology

Talvey

talquetamab

Neurology

Rystiggo

rozanolixizumab

Neurology

Vyvgart

efgartigimod alfa

Neurology

Briumvi

ublituximab